Caribou Biosciences (CRBU) Retained Earnings (2020 - 2026)

Caribou Biosciences (CRBU) has 7 years of Retained Earnings data on file, last reported at $723.6 million in Q1 2026.

• On a quarterly basis, Retained Earnings rose 433211.98% year-over-year to $723.6 million in Q1 2026; TTM through Mar 2026 was $723.6 million, a 433211.98% increase from a year earlier, with the FY2025 full-year figure at $718.6 million, up 2.5% from the prior year.
• Retained Earnings for Q1 2026 stood at $723.6 million, up from $718.6 million in the prior quarter.
• Over the last five years, Retained Earnings for CRBU reached as high as $723.6 million in Q1 2026 and fell as low as -$570.0 million in Q3 2025.
• Historically, Retained Earnings has averaged -$26.5 million across 5 years, with a median of -$170.2 million in 2022.
• Across the five-year window, Retained Earnings tumbled 171.99% in 2024 and soared 433211.98% in 2026, its largest moves.
• Year by year, Retained Earnings stood at -$197.2 million in 2022, then sank by 51.76% to -$299.3 million in 2023, then surged by 334.25% to $701.1 million in 2024, then climbed by 2.5% to $718.6 million in 2025, then rose by 0.7% to $723.6 million in 2026.
• Per Business Quant data, the three most recent Retained Earnings figures were $723.6 million in Q1 2026, $718.6 million in Q4 2025, and -$570.0 million in Q3 2025.